Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

Lanosterol 14α-Demethylase

Also: Fungal CYP51 · id CYP51A

Fungal cytochrome enzyme essential for ergosterol biosynthesis (the fungal cell-membrane sterol equivalent of mammalian cholesterol). Inhibition by azole antifungals (fluconazole, itraconazole, voriconazole) disrupts membrane integrity. Several plant compounds (allicin in garlic, terpinen-4-ol in tea tree) have antifungal mechanisms via different pathways.

7 drugs act here3 plants reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on Lanosterol 14α-Demethylase

These medications have Lanosterol 14α-Demethylase among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on Lanosterol 14α-Demethylase

Each plant below contains a named compound documented to act on Lanosterol 14α-Demethylase. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • CarvacrolPhenolic monoterpenoid

    Primary antimicrobial constituent (50-80% of oregano essential oil). Disrupts microbial membranes and inhibits ergosterol biosynthesis (mechanistically similar to azole antifungals).

  • ThymolPhenolic monoterpenoid

    Co-dominant phenolic monoterpenoid with similar antimicrobial profile; same compound abundant in thyme.

  • CinnamaldehydePhenylpropanoid aldehyde

    Studies report cinnamaldehyde may activate TRPV1, modulate NF-κB signalling, suppress TNF-α production, and inhibit fungal lanosterol 14α-demethylase (CYP51A), investigated as a basis for antifungal and anti-inflammatory activities.

  • Citral / Geraniol (terpenoids)Monoterpenoid

    In vitro antifungal activity attributed in part to membrane disruption and possible CYP51A (lanosterol 14α-demethylase) interference; mechanistic data are preclinical.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.